|
|
|
Volumn 19, Issue 4 Suppl 3, 2005, Pages 5-6
|
|
Antiangiogenic therapy in cancer: a new era has begun.
a
a
NONE
|
|
Author keywords
[No Author keywords available]
|
|
Indexed keywords
ANGIOGENESIS INHIBITOR;
BEVACIZUMAB;
MONOCLONAL ANTIBODY;
VASCULOTROPIN A;
DRUG ANTAGONISM;
DRUG DELIVERY SYSTEM;
EDITORIAL;
HUMAN;
NEOPLASM;
ONCOLOGY;
VASCULARIZATION;
ANGIOGENESIS INHIBITORS;
ANTIBODIES, MONOCLONAL;
DRUG DELIVERY SYSTEMS;
HUMANS;
MEDICAL ONCOLOGY;
NEOPLASMS;
VASCULAR ENDOTHELIAL GROWTH FACTOR A;
|
|
EID: 23444433780
PISSN: 08909091
EISSN: None
Source Type: Journal
DOI: None Document Type: Editorial |
|
Times cited : (3)
|
|
References (0)
|
